| All N = 85 | Stigma reduction n = 46 | Attention-control n = 39 | |||
---|---|---|---|---|---|---|
Gender | ||||||
 Male | 31 | 36.5% | 17 | 37.0% | 14 | 36.0% |
 Female | 49 | 57.7% | 27 | 58.7% | 22 | 56.4% |
 Not listed | 1 | 1.2% | 1 | 2.2% | 0 | 0.0% |
 Prefer not to answer | 4 | 4.7% | 1 | 2.2% | 3 | 7.7% |
Ethnicity | ||||||
 Hispanic or Latino | 3 | 3.5% | 1 | 2.2% | 2 | 5.1% |
 Not Hispanic or Latino | 80 | 94.1% | 45 | 97.8% | 35 | 89.7% |
 Missing | 2 | 2.4% | 0 | 0% | 2 | 5.1% |
Race | ||||||
 Asian | 8 | 9.4% | 6 | 13.0% | 2 | 5.1% |
 Black or African American | 6 | 7.1% | 3 | 6.5% | 3 | 7.7% |
 White | 57 | 67.1% | 29 | 63.0% | 28 | 71.8% |
 Multiple or Other | 2 | 2.4% | 1 | 2.2% | 1 | 2.5% |
 Prefer not to answer | 12 | 14.1% | 7 | 15.2% | 5 | 12.8% |
 Waivered to prescribe buprenorphine | 8 | 9.4% | 3 | 6.5% | 5 | 12.8% |
Degree | ||||||
 MD/DO | 55 | 64.7% | 30 | 65.2% | 25 | 64.1% |
 PA/NP | 30 | 35.3% | 16 | 34.8% | 14 | 35.9% |